Literature DB >> 16911674

Fixed-dose low-molecular-weight heparin, bemiparin, in the long-term treatment of venous thromboembolism in patients with transient risk factors in standard clinical practice: the FLEBUS study.

R Lecumberri, E Rosario, J Pacho, E Rocha.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16911674     DOI： 10.1111/j.1538-7836.2006.02171.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  2 in total

Review 1.  Clinical experience with bemiparin.

Authors:  José Ignacio Abad Rico; Francisco S Lozano Sánchez; Eduardo Rocha
Journal:  Drugs       Date:  2010-12-14       Impact factor: 9.546

2.  Comparison of Once-Daily Bemiparin with Twice-Daily Enoxaparin for Acute Deep Vein Thrombosis: A Multicenter, Open-Label, Randomized Controlled Trial.

Authors:  Igor A Suchkov; Javier Martinez-Gonzalez; Sebastian M Schellong; Toni Garbade; Michela Falciani
Journal:  Clin Drug Investig       Date:  2018-02       Impact factor: 2.859
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.